CheckMyRecalls

Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release…

Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release Tablets

Published
12 Aug 2026
Agency
FDA
Country
United States

The hazard

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.

Brand / company
Zydus Pharmaceuticals (USA) Inc
Codes / lots
Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 12 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.